Infliximab Treatment Report

Category: Prescription Drugs

Most Popular Types: Remicade

false

What is Infliximab?

An example of Infliximab

Infliximab is a monoclonal antibody used in the treatment of rheumatoid arthritis; Crohn's disease; psoriatic arthritis; chronic severe psoriasis; and ankylosing spondylitis. Off label used for acute graft-versus-host disease (GVHD) and juvenile rheumatoid arthritis.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
58 18 Efficacy_major Efficacy_moderate Efficacy_slight
51 17 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
26 6 Efficacy_major Efficacy_moderate Efficacy_slight
15 4 Efficacy_moderate Efficacy_none Efficacy_cant_tell
14 7 Efficacy_major Efficacy_moderate Efficacy_cant_tell
12 2 Efficacy_major Efficacy_none

See all 125 patients currently taking Infliximab

Mouse over the table for more information

Reported Dosages

Frequently reported dosages based on patients currently taking Infliximab. See all 63 dosages

  100 mg every 3 months 100 mg every 8 weeks 100 mg every 6 weeks 100 mg monthly 100 mg every other week 400 mg every 8 weeks 300 mg monthly 500 mg every 6 weeks 400 mg monthly 600 mg every 6 weeks
  8 Number of Patients: 8 13 Number of Patients: 13 8 Number of Patients: 8 7 Number of Patients: 7 7 Number of Patients: 7 7 Number of Patients: 7 4 Number of Patients: 4 5 Number of Patients: 5 5 Number of Patients: 5 4 Number of Patients: 4  

Reported Stop Reasons

Why Patients Stopped Taking Infliximab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 33   Did not seem to work: 40%
Side effects too severe 24   Side effects too severe: 29%
Other 14   Other: 17%
Doctor's advice 13   Doctor's advice: 16%
Expense 12   Expense: 14%
Change in health plan coverage 7   Change in health plan coverage: 8%
Not indicated 3   Not indicated: 4%
Personal research 1   Personal research: 1%

See all 76 patients who’ve stopped taking Infliximab

Currently Taking Infliximab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Infliximab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Infliximab

Always
49 89%
Usually
1 2%
Sometimes
3 5%
Never
2 4%

Burden

Difficulty being on treatment

Burden of Infliximab

Very
2 4%
Somewhat
18 33%
A little
19 35%
Not at all
16 29%

Cost

Paid out of pocket

Cost of Infliximab

$200+
11 38%
$100-199
2 7%
$50-99
3 10%
$25-49
2 7%
< $25
11 38%

Sort by: Helpfulness | Most Recent

4 patient evaluations for Infliximab

Purpose: RA (Rheumatoid Arthritis) (Started Aug 01, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Aug 17, 2011 800 mg Monthly Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhatSomewhat
Side effects:
Skin infections
Date
Aug 17, 2011
Advice & Tips
Remicade is infusion only. My infusions are once every 5 weeks, and they take 2-3 hours each. I feel terrible afterwards and need to go home to sleep, but usually feel good the next day. I make sure I bring a good book or some trashy magazines to make the time go by faster, and the staff at the infusion center is always very sweet. I actually find the infusion time to be relaxing, since I really can't do much while I have the IV in. I try to enjoy that down time.
  • Icon_thumb_off 0 helpful marks
Purpose: Ankylosing Spondylitis (Started Jan 18, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Apr 26, 2011 100 mg Every Other Week Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Side effects:
Nausea, Headaches
Date
Apr 26, 2011
Advice & Tips
It is better if you are squeamish about giving yourself injections because it is an iv treatment. A slight hassle because it takes up a few hours of your day just to get the treatment and usually you are feeling sick for a day or two after.
  • Icon_thumb_off 0 helpful marks
Purpose: Unable to function (Started Aug 18, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jan 12, 2011 200 mg Every 3 months Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Date
Jan 12, 2011
Advice & Tips
LOVE Remicade and really wish I could continue it.
Cost
$200+ monthly
  • Icon_thumb_on 1 helpful mark
1 2    You are at the first page First There is no previous page Prev | Next Go to the next page Last Go to the last page 

What is infliximab?

Infliximab reduces the effects of a substance in the body that can cause inflammation.

Infliximab is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease, and ankylosing spondylitis. Infliximab is also used to treat severe or disabling plaque psoriasis (raised, silvery flaking of the skin).

Infliximab is often used when other medicines have not been effective.

Infliximab may also be used for other purposes not listed in this medication guide.


Precautions

You should not use this medication if you are allergic to infliximab, if you have severe heart failure, or if you are also being treated with anakinra (Kineret).

Before using infliximab, tell your doctor if you have ever had tuberculosis, if anyone in your household has tuberculosis, or if you have recently traveled to an area where tuberculosis is common.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using infliximab, tell your doctor if you have:

  • an active or recent infection;
  • open sores or skin wounds;
  • hepatitis B;
  • congestive heart failure;
  • epilepsy or other seizure disorder;
  • chronic obstructive pulmonary disease (COPD);
  • a history of cancer;
  • a disease that affects the nerves or muscles, such as multiple sclerosis, myasthenia gravis, Guillain-Barre syndrome;
  • if you have recently been vaccinated with BCG (Bacille Calmette-Guerin); or
  • if you are scheduled to receive any vaccines.

FDA pregnancy category B. Infliximab is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether infliximab passes into breast milk. Do not use infliximab without first talking to your doctor if you are breast-feeding a baby.

Infliximab is not for use in children younger than 6 years old.

Treatment with infliximab may increase your risk of certain types of cancer, such as breast, colon, skin cancer, or lymphoma (cancer of the lymph nodes). This risk may be greater in children and young adults. You may also develop an autoimmune disorder (such as a lupus-like syndrome). Talk with your doctor about your specific risk.

Avoid contact with people who have colds, the flu, or other contagious illnesses. Contact your doctor immediately if you develop signs of infection.

Do not receive a "live” vaccine while you are being treated with infliximab.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine. An overdose of infliximab is not expected to produce life-threatening symptoms.

Contact your doctor if you miss a dose of infliximab.

Back to top

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Serious and sometimes fatal infections may occur during treatment with infliximab. Stop using infliximab and call your doctor right away if you have signs of infection such as:

  • fever, sweating, chills, tired feeling;
  • feeling short of breath;
  • cough, sore throat;
  • flu symptoms, weight loss.

Call your doctor at once if you have any of these other serious side effects:

  • chest pain, ongoing cough, coughing up blood;
  • shortness of breath with swelling of your ankles or feet;
  • numbness or tingling;
  • weak feeling in your arms or legs;
  • problems with vision;
  • seizure (convulsions);
  • pain or burning when you urinate;
  • easy bruising or bleeding, pale skin, unusual weakness;
  • red, purple, or scaly skin rash, hair loss, joint or muscle pain, mouth sores; or
  • nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Less serious side effects may include:

  • stuffy nose, sinus pain;
  • mild stomach pain;
  • mild skin rash; or
  • headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

There may be other drugs that can interact with infliximab. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Remicade and infliximab

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: